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Do the British public recognise differences in survival between
three common cancers?
KL Whitaker1, AE Simon 1, RJ Beeken1 and J Wardle*,1
1Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, Gower Street, London WC1E 6BT, UK
BACKGROUND: The recognition that cancer is not a single entity, rather that different cancers have different causes and trajectories, has
been a key development in the scientific understanding of cancer. However, little is known about the British public’s awareness of
differences between cancers. This study examined differences in perceived survivability for three common cancers with widely
disparate survival rates (breast, colorectal and lung).
METHOD: In a population-based survey, using home interviews (N¼ 2018), respondents answered a quantitative (numeric) question
on 5-year survival and a qualitative (non-numeric) question on curability, for each of the three cancers.
RESULTS: British adults correctly recognised that 5-year survival for breast cancer was higher than for colorectal cancer (CRC), which in
turn was recognised to be higher than for lung cancer. Similarly, curability was perceived to be higher for breast than CRC, and both
were perceived to be more curable than lung cancer. Awareness of survival differences did not vary by sex, age or socioeconomic
status. In terms of absolute values, there was a tendency to underestimate breast cancer survival and overestimate lung cancer
survival.
CONCLUSION: The British public appear to be aware that not all cancers are equally fatal.
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The scientific community’s understanding that cancer is not a
single entity has been an important theme in oncology over the
past century (Mukherjee, 2011). However, popular discourse and
media stories often imply a single entity: ‘the war on cancer’,
‘finding a cure for cancer’, ‘one in three of us will get cancer’.
There is concern that the general public may not realise that
different cancers have very different outcomes. Overestimating
cancer survival (equivalent to underestimating its seriousness)
may be associated with poor health behaviours such as smoking
(Donovan et al, 2006). Underestimating survival may be associated
with reluctance to participate in early detection. In previous
studies, the belief that cancer is a ‘death sentence’ has been found
to be associated with negative attitudes towards early detection
(Facione and Dodd, 1995; Burgess et al, 2001) and with lower
screening participation (Chavez et al, 1997; Pearlman et al, 1999).
Research in the United States indicates that the public are aware
of variations in outcome: people rated skin cancer as more
survivable than colorectal cancer (CRC), which was rated as more
survivable than lung cancer (Rutten et al, 2009). Similarly, an
Australian study found that breast cancer was perceived as most
survivable, followed by CRC, and then lung cancer (Jones et al,
2005). However, no similar study has been carried out in
Britain despite the fact that cultural differences could limit
generalisation across countries. We therefore used data from
a British population sample to compare estimated survival for
three common cancers distributed across the survival spectrum
(breast, colorectal and lung).
MATERIALS AND METHODS
The survey was incorporated into the BMRB (British Market
Research Bureau) omnibus survey in September 2009. The survey
uses a random location, quota-sampling technique to ensure that
the distribution of respondents (agedX15 years) across area types
matches census data; with quota controls set for sex, age,
employment status and likelihood of being at home at the time
of the interview. A specific person from the household is chosen
for interview based on them filling the quota. If the initial person is
not available, the person with the next birthday is selected (as an
unbiased method of selection). Trained interviewers carried out
computer-assisted interviews during household visits. Respon-
dents were questioned about perceived survival and perceived
curability for breast, colorectal and lung cancer, except that only
women were asked the breast cancer questions. Data were collected
from 2018 adults (937 men, 1081 women).
Quantitative survival estimates were based on the question: ‘Out
of 100 people with a [breast/colorectal/lung] cancer diagnosis, how
many do you think would be alive 5 years later’; with response
categories in 10-point intervals from 0–10% through to 91–100%.
The qualitative question (perceived curability) was assessed using
the statements ‘Many people who get [breast/colorectal/lung]
cancer can be completely cured’; with responses on 5-point Likert
scales from ‘strongly disagree’ to ‘strongly agree’.
Socioeconomic status (SES) was indexed with the National
Readership Survey classification (NRS Ltd, 2007). Group AB
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comprises people who have (or have had) higher or intermediate
managerial or professional occupations, group C1 includes super-
visory or junior managerial occupations, group C2 are skilled
manual workers, group D are semi- and unskilled manual workers
and group E are state pensioners or lowest grade workers. Age and
sex were recorded.
Statistical analysis
Analyses were done using Statistical Package for the Social Sciences
(SPSS, Chicago, IL, USA) 17.0 with rim-weighted data (BMRB Target
Group Index, 2007). Variables used to define weighting included
age, sex, social grade and standard region. We also ran the analyses
on unweighted data and there were no significant differences in the
results, so only analyses on weighted data are reported. As men did
not provide a response for perceived survival/curability of breast
cancer, men and women’s responses were analysed separately.
Descriptive statistics were conducted for perceived survival and
perceived curability. Perceived survival was indexed both with
modal scores and by treating it as a continuous scale (from 1 to 10).
For perceived survival we also categorised responses for each
cancer according to whether they were accurate using CR-UK
survival statistics (Cancer Research UK, 2011) into pessimistic
(survival estimates lower than actual survival statistics), accurate
(survival approximated actual survival) or optimistic (survival
estimates higher than actual). Perceived curability was indexed by
the proportion of people agreeing or strongly agreeing that ‘many
people who get [breast/colorectal/lung] cancer can be completely
cured’ and was also scored as a continuous scale from 1 to 5.
Repeated measures ANOVAs assessed differences between cancers.
Main effects were decomposed using Bonferroni comparisons.
RESULTS
Respondents were 47.4 years old on average, and 54% were
women. Socioeconomic status indicators were well distributed,
with 20% in group AB, 27% in C1, 19% in C2, 14% in D and 19% in
group E.
Among women, modal 5-year survival estimates indicated that
they were aware of differences between cancers, with modal values
of 71–80% for breast cancer, 51–60% for CRC and 21–30% for lung
cancer. Among men, the modal estimate for CRC (51–60%) was
higher than for lung cancer (41–50%); see Table 1.
These survival estimates indicated that as a group, respondents
were broadly realistic about breast cancer survival (current 5-year
survival is 82%) and CRC survival (current 5-year survival is 50%),
but optimistic about lung cancer survival where the current 5-year
figure is 8% (Cancer Research UK, 2011).
Categorising individual survival estimates into pessimistic,
accurate or optimistic provided directional information about
the accuracy of the survival estimates (see Table 2). This revealed a
tendency to underestimate breast cancer survival and overestimate
lung cancer survival.
The same ranking by cancer site was seen in answers to the
qualitative question, where the majority of women (73%) agreed
that many people can be completely cured for breast cancer,
compared with 48% for CRC, and only 28% for lung cancer. Men
were more likely to agree that many people who get CRC can be
completely cured (42%) than lung cancer (29%).
Treating responses as continuous variables confirmed signifi-
cant differences in perceived survival between cancer sites
(F(2,1776)¼ 480.92, Po0.001). Women perceived breast cancer
as significantly more survivable than either of the other cancers
(both P-values o0.001), and CRC as more survivable than lung
cancer (Po0.001). There were also significant differences in
perceived curability (F(2,2074)¼ 406.71, Po0.001), with breast
cancer perceived as significantly more curable than CRC
(Po0.001), which was perceived as more curable than lung cancer
(Po0.001).
Men’s responses also showed significant differences in perceived
survival (F(1,874)¼ 145.86, Po0.001) and curability (F(1,967¼
151.68, Po0.001), with CRC seen as significantly more survivable
and curable (Po0.001) than lung cancer.
Subgroup analyses (lower vs higher SES, younger vs older)
revealed the same pattern of findings (data not shown).
DISCUSSION
This is the first study to assess perceptions of differences in cancer
survival in Britain. It showed that, just like Americans and
Australians (Jones et al, 2005; Rutten et al, 2009), Britons are aware
that all cancers are not the same – at least in terms of survival.
Estimates of survival and perceived curability varied by cancer
type consistent with the rank ordering in Cancer Research UK’s
survival statistics (Cancer Research UK, 2011). Breast cancer was
perceived to be the most survivable and curable, followed by CRC,
and then lung cancer.
Interestingly, although respondents were aware of differences,
they nonetheless underestimated survival for the breast cancer and
overestimated survival for lung cancer. This may be due partly to
the well-established tendency to avoid the extremes on any rating
scale, but may also be because although the public know that
Table 1 Perceived survival and curability by cancer site for women and
men (weighted data)
Cancer
site by
sex
Modal
survival
estimate
(%)
% Agreeing
that many
people who get
[..]cancers can be
completely cured
Perceived
survival
(scored 1–10),
mean (s.d.)
Perceived
curability
(scored 1–5),
mean (s.d.)
Women (n¼ 1038a)
Breast 71–80 73 6.61 (1.96)b1 3.85 (0.96)b1
CRC 51–60 48 5.53 (2.08)2 3.44 (0.96)2
Lung 21–30 26 4.41 (2.01)3 2.89 (0.93)3
Men (n¼ 980a)
CRC 51–60 42 5.32 (2.09)1 3.34 (0.90)1
Lung 41–50 29 4.44 (2.12)2 2.93 (0.99)2
Means followed by different numbered superscripts differ significantly (Po0.001).
an’s appear different because analyses are done on weighted data. bMissing data
range from n¼ 70 (breast cancer) to n¼ 203 (colorectal cancer, CRC) for survival
estimates and n¼ 2 (breast cancer) to n¼ 3 (CRC, lung) for curability estimates.
Missing data includes ‘refused’, ‘don’t know’ and ‘not stated’ options.
Table 2 Frequency data showing perceived 5-year survival by cancer site
for men and women (weighted data)
Cancer
site by sex
Pessimistic %
(n)
Accurate %
(n)
Optimistic %
(n)
Women (n¼ 1038a)
Breast 60 (581)b 35.3 (342) 4.7 (45)
CRC 29.7 (273) 39.8 (367) 30.5 (281)
Lung ___ 9.6 (90) 90.4 (842)
Men (n¼ 980a)
CRC 30.5 (272) 41.4 (371) 28.1 (251)
Lung ___ 11.8 (109) 88.2 (811)
an’s appear different because analyses are done on weighted data. bMissing data for
survival estimates, which range from n¼ 70 (breast cancer) to n¼ 203 (colorectal
cancer, CRC), include ‘refused’, ‘don’t know’ and ‘not stated’ options.
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cancers are different in terms of outcomes, they do not realise
quite how different.
Although average (modal) survival estimates were correctly
ranked, there was considerable variability in survival estimates at
the individual level; indicating a role for public education about
cancer outcomes. While reducing fatalistic beliefs about breast
cancer survival may increase early detection behaviours, such as
screening participation and promote timely presentation, public
health campaigns aimed at encouraging people to stop smoking
may want to place more emphasis on the high mortality rates of
lung cancer.
The measures we used had advantages and disadvantages. The
use of numerical ratings for survival has the advantage of making
it possible to compare the values with ‘true’ survival, but the cost is
higher frequency of missing data than for the ‘qualitative’ question
(i.e., more people answered the curability than the survival
question). This was particularly evident for CRC, which may be
because of lower awareness of CRC than other common cancers
(Juszczyk et al, 2011). The amount of missing data did not vary by
sex or SES, but older respondents (465 years) were less likely to
answer the numeric question. Lay people may have difficulty
understanding numeric estimates of risk (Reyna et al, 2009) and
this needs to be taken into account in assessing public awareness.
In common with previous research, we used single-item scales to
measure perceptions of survival and cure, which are less reliable,
but allowed the results to be compared with previous findings
(Jones et al, 2005; Rutten et al, 2009). We found a ‘floor effect’ in
the scale for lung cancer survival because of using categories
covering 10 percentage points, which meant that the lowest
category (1–10%) contained the true survival figure. However, only
11% of respondents chose the lowest category. Finally, the fact that
only women were asked the breast cancer questions limited the
analyses in men to two cancers. The results showed that men were
significantly more optimistic about lung cancer survival than
women, although reasons for this are unclear.
Notwithstanding these caveats, these results demonstrate clearly
that concern that the public are unaware that different cancers
have different outcomes is unfounded. Men and women, from all
age and SES groups, have evidently learned that some cancers have
better outcomes and others are more likely to be fatal. Future
public information about cancer can build on this foundation.
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